Strong expansion of normal CD19-negative B-cell precursors after the use of blinatumomab in the first-line therapy of acute lymphoblastic leukaemia in children.
Ekaterina MikhailovaJulia RoumiantsevaOlga IllarionovaSvetlana LagoykoNatalia MiakovaSvetlana LebedevaLiudmila ZharikovaYulia OlshanskayaGalina NovichkovaMikhail A MaschanGuenter HenzeAlexander KarachunskiyAlexander M PopovPublished in: British journal of haematology (2021)